SCHEMBL30645929

SCHEMBL30645929

Cc1cc(O)c2c(c1)OC(C)(C)OC2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.42
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
ALDH1A1 P00352 6/20 0.41
PIM1 P11309 2/20 0.40
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 4/20 0.39
MAPT P10636 4/20 0.38
CYP3A4 P08684 3/20 0.38
ELANE P08246 3/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 2/20 0.38
USP2 O75604 1/20 0.38
BRCA1 P38398 1/20 0.38
RECQL P46063 1/20 0.38
CYP1A2 P05177 2/20 0.38
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15762161 1.00 MEN1 (0.42) MEN1KMT2AGAACNR1CNR2
SCHEMBL26604997 0.90 KMT2A (0.36) MEN1KMT2AGAACNR1CNR2
SCHEMBL9155082 0.84 ALDH1A1 (0.57) MEN1KMT2AGAAALDH1A1TDP1
SCHEMBL31014100 0.83 ALDH1A1 (0.41) GAAALDH1A1TDP1L3MBTL1TSHR
SCHEMBL26604721 0.83 ALDH1A1 (0.41) GAAALDH1A1TDP1L3MBTL1TSHR
SCHEMBL9282920 0.82 TSHR (0.44) KMT2AGAAALDH1A1TDP1L3MBTL1
SCHEMBL31013939 0.81 ALDH1A1 (0.40) GAACNR1CNR2ALDH1A1TDP1
SCHEMBL26604993 0.79 GLO1 (0.36) MEN1KMT2AGAACNR1CNR2
SCHEMBL15348611 0.79 TDP1 (0.58) MEN1KMT2AGAAALDH1A1TDP1
SCHEMBL31013887 0.78 ALDH1A1 (0.37) GAAALDH1A1TDP1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116891-A1 Oxazepin Derivative TEIJIN PHARMA LTD (JP) 2026-04-30 US disclosed
WO-2025084388-A1 CRYSTAL OF OXAZEPINE DERIVATIVE OR CRYSTAL OF SOLVATE THEREOF TEIJIN PHARMA LIMITED (JP) 2025-04-24 WO disclosed
EP-4512811-A1 OXAZEPINE DERIVATIVE Teijin Pharma Limited (JP) 2025-02-26 EP disclosed
WO-2023204308-A1 OXAZEPINE DERIVATIVE 帝人ファーマ株式会社 2023-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116891-A1 Oxazepin Derivative HCRTR2, HCRTR1, OXTR MEN1 2666/4885KMT2A 2333/4885GAA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.